Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2025-12-24 @ 9:47 PM
NCT ID:
NCT01326832
Eligibility Criteria:
Inclusion Criteria:
* younger OA patients with good bonestock
Exclusion Criteria:
1. Patients who do not understand the given information to patients
2. Competing disorder requiring treatment with anti-inflammatory drugs (NSAIDs, steroids, cytostatics).
3. Estimated remaining life expectancy \< 10 years
4. Rheumatoid arthritis or other arthritis (eg psoriatic arthritis).
5. Previous surgery on relevant hip.
6. Pain Normative and disabling osteoarthritis of the ipsilateral knee.
7. Co-mobiditet (ASA-group 3-5).
8. Neurological disorder which compromises the motor skills and rehabilitation courses.
9. Pregnancy.
10. Osteoarthritis secondary to Calvé-Legg-Perthes' disease and juvenile epifysiolysis coxae.
11. Acetabular dysplasia and secondary subluxation (Crowie grade II to IV).
12. Previously established osteoporosis or osteoporosis detected by current DEXA scan.
13. Ongoing treatment with osteoporosis medications (calcium and vitamin D, bisphosphonates, estrogen receptor modulating agents and parathyroid hormone, etc.).
14. Aseptic caputnekrosis (post-traumatic, idiopathic).
15. Deform the femoral neck (femoral length, measured medially ≤ 15 mm)
16. Varus or valgus deformity in proximal femur inc. femoral (Collum angel \< 125 ° or \> 145 °.)
17. Retroversion or anteversion femur.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01326832
Study Brief:
Protocol Section:
NCT01326832